ESC Premium Access

Is myocardial infarction a surrogate endpoint for all-cause mortality? A trial-level meta-analysis of 144 randomized controlled trials enrolling 1.2 million patients from 1972-2020

Congress Presentation

About the speaker

Doctor Kevin O'Fee

Washington University School of Medicine, St Louis (United States of America)
0 follower

28 more presentations in this session

Post-discharge major bleeding, myocardial infarction and mortality risk after coronary artery bypass grafting: A nationwide cohort study from the SWEDEHEART registry

Speaker: Doctor E. Bjoerklund (Gothenburg, SE)

Thumbnail

Trends in cardiovascular mortality of cancer patients in the US over two decades 1999-2019

Speaker: Doctor O. Kobo (Hadera, IL)

Thumbnail

Underuse of reperfusiontherapy in STEMI with cardiogenic shock. Results of the EORP ACVC EAPCI STEMI registry of the ESC.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Thumbnail

The effect of immediate coronary angiography after cardiac arrest without ST-segment elevation on left ventricular function. A sub-study of the COACT randomised trial

Speaker: Doctor J. Lemkes (Amsterdam, NL)

Thumbnail

Comparison of risk prediction models in infarct-related cardiogenic shock

Speaker: Doctor A. Freund (Leipzig, DE)

Thumbnail

Access the full session

Congress committee e-posters choice in CAD/ACS/ACC

Speakers: Doctor K. O'Fee, Doctor E. Bjoerklund, Doctor O. Kobo, Professor U. Zeymer, Doctor J. Lemkes...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual kinetic mechanism of action

27 August 2021

ESC Premium Access

Hospitalized patients with hypertension and moderate COVID-19 benefit from continuing ACEIs and ARBs: Insights from the BRACE CORONA trial

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

ESC 365 is supported by

logo Novo Nordisk